US MoCRA for SME cosmetic brands
The Modernization of Cosmetics Regulation Act (MoCRA) expanded FDA oversight of cosmetics — facility listing, product listing, safety substantiation, adverse event reporting, and labeling expectations for most brands on the US market.
Who should care
US and foreign brands selling cosmetics in the United States, contract manufacturers, and facility owners. Small businesses may have partial exemptions — verify against FDA guidance.
Official sources
SME: first 5 things
-
1
Know if MoCRA applies
Most cosmetics for US commerce are in scope; check FDA pages for definitions and exemptions.
-
2
Facility listing
Ensure manufacturing/processing facilities are listed as required.
-
3
Product listing
List products with FDA on the required cadence.
-
4
Safety substantiation
Be able to show a product is safe under labeled conditions of use.
-
5
Adverse events & labeling
Build a process for serious adverse event reporting and keep labels compliant.
Obligation map
| Topic | SME note | Source |
|---|---|---|
| Facility listing | Register applicable facilities | Official |
| Product listing | List marketed products | — |
| Safety | Adequate substantiation | — |
| Adverse events | Serious AE reporting duties | — |
| Labeling | Required statements and claims discipline | — |
Common pitfalls
- Assuming “small brand” means no MoCRA duties
- Listing once and never updating after formula or facility changes
- No process for serious adverse event reports
- Mixing drug claims into cosmetic positioning
What this page covers
Orientation for SME decision-makers. Always confirm deadlines and exemptions on FDA.gov. Not legal advice.
Track updates in Workbench, or upgrade for full Regulatory Details and follow-up tools.
Always confirm requirements against official publications before decisions.